Taking place at the Wynn in Las Vegas on November 10 through November 11th
The Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2023 is a comprehensive program that provides a multidisciplinary overview on the importance of early diagnosis and treatment considerations for patients with hepato-pancreatico-biliary cancers.
- Overview: The symposium will cover a range of topics including surgery, radiation, loco-regional approaches, and systemic therapies. It will be held from November 10 to November 11, 2023, at Encore at Wynn Las Vegas.
- Target Audience: This course is intended for surgeons, gastroenterologists, medical and radiation oncologists, laboratory scientists, and allied health professionals.
- Learning Objectives: After attending this symposium, participants should be able to understand new treatment options for pancreas, liver and biliary cancers, especially for cases with limited oligometastatic disease; recognize emerging strategies for the early detection of liver cancer; determine suitable treatments for patients, including liver transplantation, surgical resection, radiation therapy, or other loco-regional approaches; incorporate novel molecularly-targeted strategies into clinical trial participation; identify the right first and second line therapies for treating advanced pancreatic cancer, liver and biliary cancer; stay updated with the latest scientific developments in pancreatic cancer, liver and biliary cancer.
- Accreditation & Credit Designation Statements: Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
- Total Credit Hours & Costs: The registration fee for MD, DO, PhD is $610 and for Allied Health, NP, PA, RN, Fellows, Residents, or Retired is $4,851. 8.75 ABS, 8.75 AMA PRA Category 1 Credit™, 8.75 Attendance.
Hepato-pancreatico-biliary cancers represent a significant global health burden, with liver cancer being the sixth most commonly diagnosed cancer and the fourth leading cause of cancer death worldwide in 2020 (source: World Health Organization).
More on Liver Cancer